慢性阻塞性肺疾病（COPD）患者吸入性糖皮质激素的实际应用与慢性阻塞性肺疾病全球倡议（GOLD）建议的对比：GOLD 2011中的一个范式转变？ - Suppr

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

作者信息

Burgel Pierre-Régis, Deslée Gaetan, Jebrak Gilles, Brinchault Graziella, Caillaud Denis, Chanez Pascal, Court-Fortune Isabelle, Escamilla Roger, Nesme-Meyer Pascale, Paillasseur Jean-Louis, Perez Thierry, Roche Nicolas

机构信息

Hôpital Cochin, Assistance Publique Hôpitaux de Paris (AP-HP), Paris.

出版信息

Eur Respir J. 2014 Apr;43(4):1201-3. doi: 10.1183/09031936.00162313. Epub 2013 Oct 31.

DOI:10.1183/09031936.00162313

PMID:24176996

Abstract

摘要

相似文献

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?慢性阻塞性肺疾病（COPD）患者吸入性糖皮质激素的实际应用与慢性阻塞性肺疾病全球倡议（GOLD）建议的对比：GOLD 2011中的一个范式转变？

Eur Respir J. 2014 Apr;43(4):1201-3. doi: 10.1183/09031936.00162313. Epub 2013 Oct 31.

Inhaled corticosteroids in COPD: a case in favour.慢性阻塞性肺疾病中吸入性糖皮质激素：支持的一例病例

Eur Respir J. 2009 Jul;34(1):10-2. doi: 10.1183/09031936.00022809.

Inhaled corticosteroids in COPD: the case against.慢性阻塞性肺疾病中吸入性糖皮质激素：反对的理由

Eur Respir J. 2009 Jul;34(1):13-6. doi: 10.1183/09031936.00190908.

[Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].[皮质类固醇用于慢性阻塞性肺疾病患者的治疗]

Nihon Rinsho. 2003 Dec;61(12):2181-6.

Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.吸入性糖皮质激素/β2受体激动剂在慢性阻塞性气道疾病中实现治疗益处。

Chin Med J (Engl). 2007 Jun 20;120(12):1097-105.

[Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].

Rev Med Suisse. 2005 Nov 16;1(41):2673-4, 2677-9.

Do inhaled corticosteroids slow FEV1 decline in COPD after all?吸入性糖皮质激素究竟能否减缓慢性阻塞性肺疾病（COPD）患者第一秒用力呼气容积（FEV1）的下降？

Thorax. 2004 Jun;59(6):538-9; author reply 539-40.

[Inhaled corticosteroids in COPD--between pro and con?].[慢性阻塞性肺疾病中吸入性糖皮质激素——利弊权衡？]

Pneumologia. 2009 Oct-Dec;58(4):204-5.

[Role of inhaled corticosteroids in the management of COPD].吸入性糖皮质激素在慢性阻塞性肺疾病管理中的作用

Pneumonol Alergol Pol. 2009;77(2):186-91.

[Clinical efficacy of inhaled corticosteroids in COPD].吸入性糖皮质激素在慢性阻塞性肺疾病中的临床疗效

Nihon Rinsho. 2007 Apr;65(4):696-701.

引用本文的文献

Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.德国慢性阻塞性肺疾病单吸入器和多吸入器三联疗法使用者及新启用者的特征

Int J Chron Obstruct Pulmon Dis. 2024 Apr 17;19:945-956. doi: 10.2147/COPD.S431291. eCollection 2024.

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD.比较 COPD 患者使用长效抗胆碱能药物和吸入性皮质类固醇加长效β激动剂的肺炎发生率。

Sci Rep. 2023 May 20;13(1):8183. doi: 10.1038/s41598-023-35223-3.

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis.真实世界中慢性阻塞性肺疾病初诊患者的治疗：一项德国回顾性索赔数据分析。

Int J Chron Obstruct Pulmon Dis. 2022 Sep 22;17:2355-2367. doi: 10.2147/COPD.S375190. eCollection 2022.

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease.吸入性糖皮质激素使用与慢性阻塞性肺疾病全球倡议（GOLD）A组患者未来急性加重风险之间无关联。

J Pers Med. 2022 May 31;12(6):916. doi: 10.3390/jpm12060916.

Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies.吸入性皮质类固醇与阻塞性肺疾病患者结核病风险：非随机研究的系统评价和荟萃分析。

Int J Chron Obstruct Pulmon Dis. 2019 Sep 26;14:2219-2227. doi: 10.2147/COPD.S209273. eCollection 2019.

Are there specific clinical characteristics associated with physician's treatment choices in COPD?在 COPD 中，是否存在与医生治疗选择相关的特定临床特征？

Respir Res. 2019 Aug 20;20(1):189. doi: 10.1186/s12931-019-1156-1.

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.吸入性皮质类固醇治疗与 COPD 加重的变化：来自 KOLD/KOCOSS 队列的真实世界数据分析。

Respir Res. 2019 Mar 28;20(1):62. doi: 10.1186/s12931-019-1029-7.

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.来自七个拉丁美洲国家的慢性阻塞性肺疾病（COPD）患者使用的呼吸药物：LASSYC研究

Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.关于在慢性阻塞性肺疾病的临床实践中撤回吸入性皮质类固醇的建议。

Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y.

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal.慢性阻塞性肺疾病中吸入性糖皮质激素的合理使用：安全撤药的候选对象

NPJ Prim Care Respir Med. 2016 Sep 29;26:16068. doi: 10.1038/npjpcrm.2016.68.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献